Our data compilation reveals that the most common translocation partners of HMGA2 in mesenchymal tumors are chromosomes 1–3, with a preponderance of intragenic chromosome 12 aberrations. The gene discussed is HMGA2; the disease is mesenchymal cell neoplasm.